Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your synthetic biology research with our comprehensive Design-Build-Test-Learn (DBTL) platform. From computational design to automated construction and high-throughput screening, we provide end-to-end solutions for organism engineering and biomanufacturing.
Trusted by leading research and pharmaceutical institutions
AI-enhanced sequence optimization and pathway design
Automated gene synthesis and assembly
FACS, droplet microfluidics, and plate screening
Our integrated platform covers the entire Design-Build-Test-Learn cycle, enabling rapid iteration from concept to characterized organism.
Computational tools for pathway design, genetic circuit construction, and sequence optimization. Our AI-enhanced platform leverages machine learning models trained on large-scale biological datasets to predict construct performance and guide design decisions.
Automated DNA synthesis and assembly services powered by high-throughput platforms. We support multiple assembly methods including Gibson Assembly, Golden Gate, and specialized enzymatic approaches for optimal flexibility.
High-throughput screening using FACS, droplet microfluidics, and plate-based assays for rapid phenotype characterization.
Machine learning integration to analyze experimental data and guide iterative design improvements.
SBOL and SBML compliant data management for seamless integration with existing workflows.
Complete cycle support enabling rapid iteration from design through characterization.
Get expert consultation on integrating our platform into your workflow.
Industry-leading computational and experimental tools for accelerated synthetic biology development.
AI-enhanced design tools leveraging machine learning models trained on extensive biological datasets for accurate performance prediction and optimization.
Multiple standardized assembly methods including Gibson Assembly and Golden Gate for flexible construction of genetic constructs from simple to complex systems.
Automated screening platforms including FACS and droplet microfluidics enabling rapid characterization of large variant libraries.
Comprehensive specifications for our synthetic biology platform services.
| Service Phase | Capabilities | Throughput |
|---|---|---|
| Design | Pathway design, circuit simulation, sequence optimization, ML prediction | Unlimited in silico design |
| Build | Gene synthesis, multi-fragment assembly, cloning, library construction | Up to thousands of constructs per project |
| Test | FACS screening, droplet assays, plate-based phenotyping, sequencing QC | Millions of variants via FACS |
| Learn | Data analysis, ML model training, design iteration recommendations | Automated data integration |
Note: Technical specifications and capabilities vary by project requirements. Please contact us for detailed project-specific specifications and capability assessments.
Our streamlined workflow enables rapid iteration from design concept to characterized organism.
Computational pathway and circuit design with ML-assisted optimization
Automated DNA synthesis and assembly of genetic constructs
High-throughput screening and phenotypic characterization
ML analysis of experimental data and design refinement
Cycle repeats until optimal design achieved
Integrated workflow reduces iteration time compared to fragmented approaches.
ML integration enables data-informed design choices and rapid optimization.
Adaptable to specific project requirements and organism targets.
Our synthetic biology platform supports diverse applications across multiple industries.
Engineer microbial cell factories for sustainable production of chemicals, fuels, and materials through optimized metabolic pathways.
Accelerate drug discovery and development through engineered biological systems and therapeutic protein production.
Develop improved crop varieties and sustainable agricultural solutions through synthetic biology approaches.
Create novel genetic parts, circuits, and biosensors for advancing fundamental biological research.
Engineer biological systems for production of novel materials with tailored properties.
Develop biological systems for bioremediation, carbon capture, and sustainable manufacturing.
See how researchers have accelerated their synthetic biology projects using our platform.
"The integrated DBTL platform dramatically reduced our development time for an engineered yeast strain. The ML-assisted design suggestions led to improved pathway balance."
Research University
Metabolic Engineering Lab
"High-throughput screening capabilities allowed us to characterize thousands of promoter variants in weeks. The data quality was excellent and the turnaround was impressive."
Pharmaceutical Company
Strain Development Team
"The platform's SBOL compliance made it easy to share designs with collaborators. The standardized data format simplified our multi-site project significantly."
International Consortium
Synthetic Biology Network
Key publications supporting our synthetic biology platform technologies and methodologies.
Authors: Kitano S, Lin C, Foo JL, Chang MW
Journal: PLoS Biology 21(4): e3002116 (2023)
DOI: 10.1371/journal.pbio.3002116
Comprehensive review of DBTL cycle and machine learning integration in synthetic biology.
Authors: Appleton E, Densmore D, Bhatia S, et al.
Journal: Cold Spring Harb Perspect Biol 14:a040089 (2022)
DOI: 10.1101/cshperspect.a040089
Survey of bio-design automation tools covering specification, design, build, test, and learn areas.
Authors: Hérisson J, Duigou T, du Lac M, et al.
Journal: Nature Communications 13:5082 (2022)
DOI: 10.1038/s41467-022-32661-x
End-to-end metabolic pathway design workflow combining retrosynthesis and automated assembly.
Authors: Hamedirad M, Chao R, Weisberg S, Lian J, Sinha S, Zhao H
Journal: ACS Synthetic Biology 12(3):794-807 (2023)
DOI: 10.1021/acssynbio.3c00186
Framework for testing machine learning methods in iterative DBTL cycles.
Authors: Dixon TA, Freemont PS, Johnson RA, Pretorius IS
Journal: Nature Communications 13:3516 (2022)
DOI: 10.1038/s41467-022-31265-9
Proposes establishment of a Global Forum on Synthetic Biology to engage policymakers and practitioners across borders.
Find answers to common questions about our synthetic biology platform services.
The DBTL cycle is the foundational framework of synthetic biology. Design involves creating genetic constructs in silico; Build refers to physically constructing those constructs; Test involves measuring the performance of built constructs; and Learn uses the experimental data to inform the next round of design. Our platform supports all four phases with integrated tools and automation.
Our platform leverages ML in multiple ways. During the Design phase, ML models predict construct performance to guide optimization. During the Learn phase, algorithms analyze experimental data to identify patterns and recommend design improvements. We use Gaussian Process Regression for small datasets and neural networks for sequence-function prediction.
We support a wide range of host organisms including E. coli, yeast (Saccharomyces cerevisiae, Pichia pastoris), Bacillus subtilis, and various mammalian cell lines. Our platform also supports non-model organisms with custom optimization workflows.
Our platform offers multiple screening modalities. FACS-based screening can analyze millions of cells per experiment. Droplet microfluidics enables ultra-high-throughput screening in picoliter-scale droplets. Plate-based screening provides flexible format options for various assay types.
Yes, our platform fully supports SBOL (Synthetic Biology Open Language) and SBML (Systems Biology Markup Language) standards. This ensures compatibility with other synthetic biology tools and facilitates data sharing and collaboration.
Our platform is designed for flexibility. We offer both full-service project execution and modular integration with existing workflows. API access and standardized data formats enable seamless integration with laboratory information management systems and external tools.
We support projects ranging from single construct validation to large-scale library construction and screening. Our flexible service tiers are designed to accommodate academic research projects, early-stage biotech, and established pharmaceutical companies.
Quality assurance is built into every step of our workflow. We implement rigorous QC at each phase, standardized protocols, automated documentation, and comprehensive data packages. Our ML models are trained on high-quality datasets and validated against independent test sets.
Get a customized quote for your Synthetic Biology Platform project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.